biomarker

Displaying 1 - 2 of 2


Millions of patients now able to benefit from Medicare approved test

Congratulations to a Vanderbilt research collaborator on receiving Medicare approval of a diagnostic test for patients with advanced non-small cell lung cancer (NSCLC).